Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Management of the Patient with Malignant Hemispheric Stroke.

Guanci MM.

Crit Care Nurs Clin North Am. 2020 Mar;32(1):51-66. doi: 10.1016/j.cnc.2019.11.003. Epub 2019 Dec 23. Review.

PMID:
32014161
2.

Gender Differences in Longitudinal Associations Between Intimate Care, Resiliency, and Depression Among Informal Caregivers of Patients Surviving the Neuroscience Intensive Care Unit.

Lin A, Vranceanu AM, Guanci M, Salgueiro D, Rosand J, Zale EL.

Neurocrit Care. 2020 Apr;32(2):512-521. doi: 10.1007/s12028-019-00772-x.

PMID:
31270671
3.

Intermittent CSF drainage and rapid EVD weaning approach after subarachnoid hemorrhage: association with fewer VP shunts and shorter length of stay.

Rao SS, Chung DY, Wolcott Z, Sheriff F, Khawaja AM, Lee H, Guanci MM, Leslie-Mazwi TM, Kimberly WT, Patel AB, Rordorf GA.

J Neurosurg. 2019 Apr 26:1-6. doi: 10.3171/2019.1.JNS182702. [Epub ahead of print]

PMID:
31026832
4.

Discovery of Stereospecific PARP-1 Inhibitor Isoindolinone NMS-P515.

Papeo G, Orsini P, Avanzi NR, Borghi D, Casale E, Ciomei M, Cirla A, Desperati V, Donati D, Felder ER, Galvani A, Guanci M, Isacchi A, Posteri H, Rainoldi S, Riccardi-Sirtori F, Scolaro A, Montagnoli A.

ACS Med Chem Lett. 2019 Mar 13;10(4):534-538. doi: 10.1021/acsmedchemlett.8b00569. eCollection 2019 Apr 11.

PMID:
30996792
5.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Bader MK, Figueroa SA, Mathiesen C, Blissitt PA, Guanci MM, Hamilton LA, Fox L, Wavra T.

Ther Hypothermia Temp Manag. 2019 Mar;9(1):90-95. doi: 10.1089/ther.2019.29056.mkb. Epub 2019 Feb 6. No abstract available.

PMID:
30724671
6.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Hill M, Cahoon WD Jr, Guanci MM, Blissitt PA, Hamilton LA.

Ther Hypothermia Temp Manag. 2018 Jun;8(2):121-124. doi: 10.1089/ther.2018.29042.mkb. Epub 2018 May 9. No abstract available.

PMID:
29742037
7.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Figueroa SA, Blissitt PA, Livesay S, Wavra T, Guanci MM.

Ther Hypothermia Temp Manag. 2017 Dec;7(4):231-234. doi: 10.1089/ther.2017.29037.mkb. Epub 2017 Oct 23. No abstract available.

PMID:
29058528
8.

The Implementation of Targeted Temperature Management: An Evidence-Based Guideline from the Neurocritical Care Society.

Madden LK, Hill M, May TL, Human T, Guanci MM, Jacobi J, Moreda MV, Badjatia N.

Neurocrit Care. 2017 Dec;27(3):468-487. doi: 10.1007/s12028-017-0469-5. Review.

PMID:
29038971
9.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Cahoon WD Jr, Figueroa SA, Wavra T, Guanci MM, Mathiesen C, Hamilton LA.

Ther Hypothermia Temp Manag. 2017 Jun;7(2):111-115. doi: 10.1089/ther.2017.29027.mkb. Epub 2017 May 10. No abstract available.

PMID:
28617214
10.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Figueroa SA, Guanci MM, Blissitt PA, Cahoon WD Jr.

Ther Hypothermia Temp Manag. 2017 Mar;7(1):61-64. doi: 10.1089/ther.2017.29025.mkb. Epub 2017 Jan 24. No abstract available.

PMID:
28117626
11.

Performance of Spectrogram-Based Seizure Identification of Adult EEGs by Critical Care Nurses and Neurophysiologists.

Amorim E, Williamson CA, Moura LMVR, Shafi MM, Gaspard N, Rosenthal ES, Guanci MM, Rajajee V, Westover MB.

J Clin Neurophysiol. 2017 Jul;34(4):359-364. doi: 10.1097/WNP.0000000000000368.

12.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Bader MK, Guanci MM, Figueroa SA, Brophy GM, Laux C.

Ther Hypothermia Temp Manag. 2016 Aug;6(3):146-9. doi: 10.1089/ther.2016.29016.mkb. Epub 2016 Aug 9. No abstract available.

PMID:
27504625
13.

Clinical Development and Implementation of an Institutional Guideline for Prospective EEG Monitoring and Reporting of Delayed Cerebral Ischemia.

Muniz CF, Shenoy AV, OʼConnor KL, Bechek SC, Boyle EJ, Guanci MM, Tehan TM, Zafar SF, Cole AJ, Patel AB, Westover MB, Rosenthal ES.

J Clin Neurophysiol. 2016 Jun;33(3):217-26. doi: 10.1097/WNP.0000000000000281. Review.

14.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Laux C, Guanci MM, Figueroa SA, Francis KE, Livesay SL, Mathiesen C.

Ther Hypothermia Temp Manag. 2016 Mar;6(1):52-6. doi: 10.1089/ther.2016.29009.mkb. No abstract available.

PMID:
26866958
15.

The Insertion and Management of External Ventricular Drains: An Evidence-Based Consensus Statement : A Statement for Healthcare Professionals from the Neurocritical Care Society.

Fried HI, Nathan BR, Rowe AS, Zabramski JM, Andaluz N, Bhimraj A, Guanci MM, Seder DB, Singh JM.

Neurocrit Care. 2016 Feb;24(1):61-81. doi: 10.1007/s12028-015-0224-8. Review.

PMID:
26738503
16.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Figueroa SA, Leary M, Guanci MM, Mathiesen C, Delfin G, Bader MK.

Ther Hypothermia Temp Manag. 2015 Dec;5(4):235-9. doi: 10.1089/ther.2015.29006.mkb. Epub 2015 Nov 23. No abstract available.

PMID:
26595142
17.

Clinical Q & A: Translating Therapeutic Temperature Management from Theory to Practice.

Wavra T, Laux C, Guanci MM, Figueroa SA, Brophy GM, Kurczewski L, Livesay SL.

Ther Hypothermia Temp Manag. 2015 Sep;5(3):177-81. doi: 10.1089/ther.2015.29002.mkb. Epub 2015 Aug 18. No abstract available.

PMID:
26284506
18.

Clinical Q & A: Translating therapeutic temperature management from theory to practice.

Bader MK, Baumann JJ, Figueroa SA, Laux C, Guanci MM, Mathiesen C, Livesay SL.

Ther Hypothermia Temp Manag. 2015 Jun;5(2):110-3. doi: 10.1089/ther.2015.1506. No abstract available.

PMID:
26057856
19.

Clinical Q & A: Translating therapeutic temperature management from theory to practice.

Bader MK, Guanci MM, Figueroa SA, Leary M, Baumann JJ, Livesay S, Ray TD.

Ther Hypothermia Temp Manag. 2014 Sep;4(3):145-8. doi: 10.1089/ther.2014.1510. Epub 2014 Jul 31. No abstract available.

PMID:
25078530
20.

Assessment of satisfaction with care among family members of survivors in a neuroscience intensive care unit.

Hwang DY, Yagoda D, Perrey HM, Tehan TM, Guanci M, Ananian L, Currier PF, Cobb JP, Rosand J.

J Neurosci Nurs. 2014 Apr;46(2):106-16. doi: 10.1097/JNN.0000000000000038.

21.

Consistency of communication among intensive care unit staff as perceived by family members of patients surviving to discharge.

Hwang DY, Yagoda D, Perrey HM, Tehan TM, Guanci M, Ananian L, Currier PF, Cobb J, Rosand J.

J Crit Care. 2014 Feb;29(1):134-8.

PMID:
24475496
22.

Anxiety and depression symptoms among families of adult intensive care unit survivors immediately following brief length of stay.

Hwang DY, Yagoda D, Perrey HM, Currier PF, Tehan TM, Guanci M, Ananian L, Cobb JP, Rosand J.

J Crit Care. 2014 Apr;29(2):278-82. doi: 10.1016/j.jcrc.2013.11.022. Epub 2013 Dec 12.

PMID:
24411107
23.

Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90).

Brasca MG, Mantegani S, Amboldi N, Bindi S, Caronni D, Casale E, Ceccarelli W, Colombo N, De Ponti A, Donati D, Ermoli A, Fachin G, Felder ER, Ferguson RD, Fiorelli C, Guanci M, Isacchi A, Pesenti E, Polucci P, Riceputi L, Sola F, Visco C, Zuccotto F, Fogliatto G.

Bioorg Med Chem. 2013 Nov 15;21(22):7047-63. doi: 10.1016/j.bmc.2013.09.018. Epub 2013 Sep 19. Erratum in: Bioorg Med Chem. 2014 Jan 1;22(1):662.

PMID:
24100158
24.

Ventriculitis of the central nervous system.

Guanci MM.

Crit Care Nurs Clin North Am. 2013 Sep;25(3):399-406. doi: 10.1016/j.ccell.2013.04.005. Review.

PMID:
23981456
25.

NMS-E973, a novel synthetic inhibitor of Hsp90 with activity against multiple models of drug resistance to targeted agents, including intracranial metastases.

Fogliatto G, Gianellini L, Brasca MG, Casale E, Ballinari D, Ciomei M, Degrassi A, De Ponti A, Germani M, Guanci M, Paolucci M, Polucci P, Russo M, Sola F, Valsasina B, Visco C, Zuccotto F, Donati D, Felder E, Pesenti E, Galvani A, Mantegani S, Isacchi A.

Clin Cancer Res. 2013 Jul 1;19(13):3520-32. doi: 10.1158/1078-0432.CCR-12-3512. Epub 2013 May 14.

26.

Synthesis and SAR of new pyrazolo[4,3-h]quinazoline-3-carboxamide derivatives as potent and selective MPS1 kinase inhibitors.

Caldarelli M, Angiolini M, Disingrini T, Donati D, Guanci M, Nuvoloni S, Posteri H, Quartieri F, Silvagni M, Colombo R.

Bioorg Med Chem Lett. 2011 Aug 1;21(15):4507-11. doi: 10.1016/j.bmcl.2011.05.122. Epub 2011 Jun 14.

PMID:
21723120
27.

Neurologic examination and extubation outcome in the neurocritical care unit.

Anderson CD, Bartscher JF, Scripko PD, Biffi A, Chase D, Guanci M, Greer DM.

Neurocrit Care. 2011 Dec;15(3):490-7. doi: 10.1007/s12028-010-9369-7.

PMID:
20428967
28.

Acute ischemic stroke review.

Hinkle JL, Guanci MM.

J Neurosci Nurs. 2007 Oct;39(5):285-93, 310. Review.

PMID:
17966295
29.

Rapid infusion of cold saline (4 degrees C) as adjunctive treatment of fever in patients with brain injury.

Badjatia N, Bodock M, Guanci M, Rordorf GA.

Neurology. 2006 Jun 13;66(11):1739-41.

PMID:
16769952
30.

Pharmacokinetics and excretion of dalbavancin in the rat.

Cavaleri M, Riva S, Valagussa A, Guanci M, Colombo L, Dowell J, Stogniew M.

J Antimicrob Chemother. 2005 Mar;55 Suppl 2:ii31-5.

PMID:
15750035
31.

Benzo(a)pyrene diolepoxide-haemoglobin and albumin adducts at low levels of benzo(a)pyrene exposure.

Pastorelli R, Guanci M, Cerri A, Minoia C, Carrer P, Negri E, Fanelli R, Airoldi L.

Biomarkers. 2000;5(4):245-51. doi: 10.1080/135475000413791.

PMID:
23885977
32.

Role for telemedicine in acute stroke. Feasibility and reliability of remote administration of the NIH stroke scale.

Shafqat S, Kvedar JC, Guanci MM, Chang Y, Schwamm LH.

Stroke. 1999 Oct;30(10):2141-5.

PMID:
10512919
33.

Spinal cord trauma.

Buckley DA, Guanci MM.

Nurs Clin North Am. 1999 Sep;34(3):661-87. Review.

PMID:
10433653
34.

Seasonal effect on airborne pyrene, urinary 1-hydroxypyrene, and benzo(a)pyrene diol epoxide-hemoglobin adducts in the general population.

Pastorelli R, Guanci M, Restano J, Berri A, Micoli G, Minoia C, Alcini D, Carrer P, Negri E, La Vecchia C, Fanelli R, Airoldi L.

Cancer Epidemiol Biomarkers Prev. 1999 Jun;8(6):561-5.

35.

Impact of inherited polymorphisms in glutathione S-transferase M1, microsomal epoxide hydrolase, cytochrome P450 enzymes on DNA, and blood protein adducts of benzo(a)pyrene-diolepoxide.

Pastorelli R, Guanci M, Cerri A, Negri E, La Vecchia C, Fumagalli F, Mezzetti M, Cappelli R, Panigalli T, Fanelli R, Airoldi L.

Cancer Epidemiol Biomarkers Prev. 1998 Aug;7(8):703-9.

36.

3,4 Dichloroaniline-haemoglobin adducts in humans: preliminary data on agricultural workers exposed to propanil.

Pastorelli R, Catenacci G, Guanci M, Fanelli R, Valoti E, Minoia C, Airoldi L.

Biomarkers. 1998;3(3):227-33. doi: 10.1080/135475098231246.

PMID:
23899332
37.

Hemoglobin adducts of benzo[a]pyrene diolepoxide in newspaper vendors: association with traffic exhaust.

Pastorelli R, Restano J, Guanci M, Maramonte M, Magagnotti C, Allevi R, Lauri D, Fanelli R, Airoldi L.

Carcinogenesis. 1996 Nov;17(11):2389-94.

PMID:
8968053
38.

Aromatic DNA adducts in lymphocytes of humans working at high and low traffic density areas.

Yang K, Airoldi L, Pastorelli R, Restano J, Guanci M, Hemminki K.

Chem Biol Interact. 1996 Aug 14;101(2):127-36.

PMID:
8760394
39.

An approach to the care of patients with Guillain-Barré syndrome.

Griswold K, Guanci MM, Ropper AH.

Heart Lung. 1984 Jan;13(1):66-72.

PMID:
6559188

Supplemental Content

Loading ...
Support Center